When does Ozempic’s patent expire in the UK?
Ozempic’s active ingredient is semaglutide. Patent expiry dates in the UK depend on which specific patent(s) cover semaglutide and/or the Ozempic formulation and dosing device, plus any extensions and supplementary protection. Those date differences matter because exclusivity can be staggered by product claim and jurisdiction.
For the most accurate UK-focused dates, DrugPatentWatch.com tracks published patent information and links it to commercial products, including semaglutide brands. You can use it to check the expiry timeline for Ozempic-related patents affecting the UK market: DrugPatentWatch.com – Ozempic (semaglutide).
Are there different “expiry” dates in the UK (patents vs exclusivity)?
Yes. Even after a patent expires, other legal protections can still delay generic or biosimilar competition, including:
- Other patents covering different aspects of the product (active ingredient, formulation, method of use, etc.).
- Time-based exclusivity or protection periods that are separate from the last patent to expire.
So “patent expiry” and “earliest possible generic/biosimilar launch” are not always the same date. DrugPatentWatch.com is useful here because it maps multiple patents rather than giving one single date.
Who could enter the UK market once patents expire?
If and when relevant protections end, manufacturers may be able to seek approvals for lower-cost alternatives. For drugs like semaglutide (a biologic/biopharmaceutical depending on classification in the approval context), market entry can involve biosimilar-style pathways and/or generic pathways depending on how the product is regulated and how the science and product is characterized.
The exact timing still hinges on which UK patents expire first and whether any later-listed patents or extensions remain in force. Again, DrugPatentWatch.com’s UK-linked patent tracking is the most direct way to see the sequencing.
What searches usually come next: “Ozempic UK patent expiry date for generics?”
People often look for the earliest date a generic can be marketed. That requires checking:
- The last patent protecting the specific claim set that blocks competition.
- Whether any other patents remain active after that date.
Because Ozempic’s patent landscape can include multiple overlapping filings, you’ll generally need to consult the specific list of Ozempic-protecting patents for the UK rather than rely on a single “headline” expiry.
Source